Arne Matthys's research while affiliated with Ghent University and other places

Publications (3)

Article
The pandemic readiness toolbox needs to be extended, targeting different biomolecules, using orthogonal experimental set-ups. Here, we build on our Cov-MS effort using LC-MS, adding SISCAPA technology to enrich proteotypic peptides of the SARS-CoV-2 nucleocapsid (N) protein from trypsin-digested patient samples. The Cov2MS assay is compatible with...
Preprint
Full-text available
INTRODUCTION The pandemic readiness toolbox needs to be extended, providing diagnostic tools that target different biomolecules, using orthogonal experimental setups and fit-for-purpose specification of detection. Here we build on a previous Cov-MS effort that used liquid chromatography-mass spectrometry (LC-MS) and describe a method that allows ac...

Citations

... Several academic laboratories and industrial partners have established a Cov-MS consortium to translate the technology from analytical laboratories to clinics [210]. The Cov²MS assay was developed to diagnose SARS-CoV-2 nasopharyngeal swabs, saliva and blood plasma with a higher sensitivity and proved to be reproducible across different laboratories [211,212]. The assay can be used to monitor dozen pathogens in pooled patient samples for early warning system for impending epidemics and pandemics and subsequent rapid development of vaccines and diagnostics [212,213]. ...